APLASTIC ANEMIA
Clinical trials for APLASTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new APLASTIC ANEMIA trials appear
Sign up with your email to follow new studies for APLASTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy offers hope for rare blood disorder patients
Disease control Not yet recruitingThis study is testing an experimental cell therapy called CK0801 for adults with aplastic anemia, a rare and serious bone marrow disorder. The treatment involves infusing specially prepared immune cells from donated umbilical cord blood to help restore the body's ability to make …
Matched conditions: APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Cellenkos, Inc. • Aim: Disease control
Last updated Apr 01, 2026 21:26 UTC
-
New hope for young patients with rare blood disorder
Disease control Not yet recruitingThis study aims to see if adding the drug romiplostim to standard immunosuppressive therapy helps children and young adults (ages 2-21) with severe aplastic anemia. The goal is to improve their blood cell counts and reduce the need for transfusions. The main measure of success is…
Matched conditions: APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Anjali Sharathkumar • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for patients with bone marrow disease that Won't respond to treatment
Disease control Not yet recruitingThis early-stage study is testing a drug called daratumumab in adults with a severe form of aplastic anemia that has not responded to or has come back after standard treatments. The main goals are to find a safe dose and see if the drug can help improve patients' blood counts. Th…
Matched conditions: APLASTIC ANEMIA
Phase: PHASE1, PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC